Compare Mutual Funds
ITI Pharma and Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹500
-
Expense Ratio
2.62
-
NAV
₹18.21
-
Fund Started
18 Oct 2021
-
Fund Size
₹276.23 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
-
1 Year
10.38%
-
3 Year
17.95%
-
5 Year
-
-
Equity
99.27%
-
Cash
0.73%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.58% |
Divi's Laboratories Ltd. | 9.23% |
Apollo Hospitals Enterprise Ltd. | 5.72% |
Max Healthcare Institute Ltd. | 4.84% |
Torrent Pharmaceuticals Ltd. | 4.75% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Cipla Ltd. | 4.22% |
Laurus Labs Ltd. | 4.02% |
Aurobindo Pharma Ltd. | 3.97% |
Mankind Pharma Ltd. | 3.31% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
-
Launch Date
18 Oct 2021
-
